20/20 Biolabs, Inc. Common Stock

AIDX XNAS • SERVICES-TESTING LABORATORIES

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

Short interest (Jul 15)

2.0%

Net Short (Jul 27 ): 0.0%

Borrow Fee

23.25%

↑ 1.0%

Available Shares

400K

↓ 18.2%

Price Chart

Company Overview

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Company Info

Exchange: NASDAQ

Industry: SERVICES-TESTING LABORATORIES

CIK: 0001139685

Asset Type: CS

Market Data

Market Cap: $6,015,338

Employees: 14

Status: Active

Short Interest

Current Borrow Fee 23.25%

Range: 23.25% - 23.25%

Available Shares 400K

Range: 150K - 350K

Recent Changes

Fee Change: ↓ 6.2%

Available Change: ↑ 33.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime